ILC Therapeutics completes £3.5 million funding round

Lanarkshire-based biotechnology company ILC Therapeutics has completed a £3.5m pre-IPO funding round.

Investors include Los Angeles-based lawyer and investor Robert Kopple; St Andrews-based Eos Angel Investment Syndicate; Scottish Enterprise; and members of ILCT’s management.

Read more HERE.